ArticleFrontiers in cell and developmental biology2026
Regulation of H-type angiogenesis and permeability in the subchondral bone of osteoarthritis: the role of Slit3 and the Robo4/Rac1-GTP/ROS axis.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subchondral bone H-type angiogenesis and increased permeability are critical in osteoarthritis (OA) progression, yet the underlying regulatory mechanisms remain unclear. This study utilized proteomic analysis to identify significantly elevated expression of Slit guidance ligand 3 (Slit3) and Ras-related C3 botulinum toxin substrate 1 (Rac1) in the subchondral bone of patients with OA, both associated with angiogenesis and permeability. Experimental validation revealed that Slit3 and Rac1-GTP, rather than total Rac1, drive increased H-type angiogenesis and permeability. To further investigate, we exogenously added Slit3 recombinant protein to mimic the effect of non-ECs secreting Slit3 in the subchondral bone microenvironment on endothelial cells (ECs). Exogenous Slit3 significantly promoted migration, tube formation, and permeability in H-type ECs. An anti-Roundabout guidance receptor 4 (Robo4) antibody inhibited these effects and suppressed Rac1-GTP expression and reactive oxygen species (ROS) levels in ECs. Further investigation revealed that Rac1-GTP and ROS inhibitors could block the effects of exogenous Slit3 on H-type endothelial cell migration, tube formation, and permeability. In in vivo experiments, knockout of Slit3 aggravated early OA in destabilization of the medial meniscus (DMM) mice by altering cartilage and subchondral bone structure but alleviated late-stage OA. Moreover, Slit3 promoted H-type angiogenesis and permeability in the subchondral bone of DMM mice through the Robo4/Rac1-GTP signaling pathway, consistent with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.